TY - JOUR
KW - Adult
KW - Age of Onset
KW - Analgesics, Opioid/adverse effects
KW - Comorbidity
KW - Female
KW - Health Status
KW - Humans
KW - Male
KW - Methadone/therapeutic use
KW - Opiate Substitution Treatment/statistics & numerical data
KW - Opioid-Related Disorders/drug therapy/epidemiology
KW - Young Adult
KW - Methadone
KW - opioid substitution treatment
KW - opioid use disorder
KW - Risk prediction
KW - substance use
AU - Leen Naji
AU - Brittany Burns Dennis
AU - Monica Bawor
AU - Michael Varenbut
AU - Jeff Daiter
AU - Carolyn Plater
AU - Guillaume Pare
AU - David C. Marsh
AU - Andrew Worster
AU - Dipika Desai
AU - James MacKillop
AU - Lehana Thabane
AU - Zainab Samaan
A1 - 
AB - BACKGROUND: Opioid use disorder (OUD) affects approximately 21.9 million people worldwide. This study aims to determine the association between age of onset of opioid use and comorbid disorders, both physical and psychiatric, in patients receiving methadone maintenance treatment (MMT) for OUD. Understanding this association may inform clinical practice about important prognostic factors of patients on MMT, enabling clinicians to identify high-risk patients. METHODS: This study includes data collected between June 2011 and August 2016 for the Genetics of Opioid Addiction research collaborative between McMaster University and the Canadian Addiction Treatment Centers. All patients were interviewed by trained health professionals using the Mini-International Neuropsychiatric Interview and case report forms. Physical comorbidities were verified using patients' electronic medical records. A multi-variable logistic regression model was constructed to determine the strength of the association between age of onset of opioid use and the presence of physical or psychiatric comorbidity while adjusting for current age, sex, body mass index, methadone dose and smoking status. RESULTS: Data from 627 MMT patients with a mean age of 38.8 years (SD = 11.07) were analyzed. Individuals with an age of onset of opioid use younger than 18 years were found to be at higher odds for having a physical or psychiatric comorbid disorder compared to individuals with an age of onset of opioid use of 31 years or older (odds ratio 2.94, 95% confidence interval 1.20, 7.19, p = 0.02). A significant association was not found between the risk of having a comorbidity and an age of onset of opioid use between 18 and 25 years or 26 and 30 years, compared to an age of onset of opioid use of 31 years or older. CONCLUSION: Our study demonstrates that the younger one begins to use opioids, the greater their chance of having a physical or psychiatric co-morbidity. Understanding the risk posed by an earlier onset of opioid use for the later development of comorbid disorders informs clinical practice about important prognostic predictors and aids in the identification of high-risk patients.
AD - Michael Degroote School of Medicine, McMaster University, Hamilton, Canada.; St. George's University of London, London, UK.; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada.; St. George's University of London, London, UK.; Canadian Addiction Treatment Centres, Richmond Hill, Canada.; Canadian Addiction Treatment Centres, Richmond Hill, Canada.; Canadian Addiction Treatment Centres, Richmond Hill, Canada.; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada.; Canadian Addiction Treatment Centres, Richmond Hill, Canada.; Northern Ontario School of Medicine, Sudbury, ON, Canada.; Canadian Addiction Treatment Centres, Richmond Hill, Canada.; Department of Medicine, Hamilton General Hospital, Hamilton, Canada.; Population Genomic Program, Chanchalani Research Centre, McMaster University, Hamilton, Canada.; Peter Boris Centre for Addictions Research, Hamilton, Canada.; Department of Psychiatry and Behavioural Neuroscience, McMaster University, 100 West 5th Street, Hamilton, ON, L8N 3K7, Canada.; Departments of Pediatrics and Anesthesia, McMaster University, Hamilton, Canada.; Centre for Evaluation of Medicine, St Joseph's Healthcare, Hamilton, Canada.; Biostatistics Unit, Father Sean O'Sullivan Research Centre, St Joseph's Healthcare, Hamilton, Canada.; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada. samaanz@mcmaster.ca.; Population Genomic Program, Chanchalani Research Centre, McMaster University, Hamilton, Canada. samaanz@mcmaster.ca.; Peter Boris Centre for Addictions Research, Hamilton, Canada. samaanz@mcmaster.ca.; Department of Psychiatry and Behavioural Neuroscience, McMaster University, 100 West 5th Street, Hamilton, ON, L8N 3K7, Canada. samaanz@mcmaster.ca.
BT - Addiction science & clinical practice
C5 - Healthcare Disparities; Measures; Opioids & Substance Use
CP - 1
CY - England
DO - 10.1186/s13722-017-0074-0
IS - 1
JF - Addiction science & clinical practice
LA - eng
M1 - Journal Article
N2 - BACKGROUND: Opioid use disorder (OUD) affects approximately 21.9 million people worldwide. This study aims to determine the association between age of onset of opioid use and comorbid disorders, both physical and psychiatric, in patients receiving methadone maintenance treatment (MMT) for OUD. Understanding this association may inform clinical practice about important prognostic factors of patients on MMT, enabling clinicians to identify high-risk patients. METHODS: This study includes data collected between June 2011 and August 2016 for the Genetics of Opioid Addiction research collaborative between McMaster University and the Canadian Addiction Treatment Centers. All patients were interviewed by trained health professionals using the Mini-International Neuropsychiatric Interview and case report forms. Physical comorbidities were verified using patients' electronic medical records. A multi-variable logistic regression model was constructed to determine the strength of the association between age of onset of opioid use and the presence of physical or psychiatric comorbidity while adjusting for current age, sex, body mass index, methadone dose and smoking status. RESULTS: Data from 627 MMT patients with a mean age of 38.8 years (SD = 11.07) were analyzed. Individuals with an age of onset of opioid use younger than 18 years were found to be at higher odds for having a physical or psychiatric comorbid disorder compared to individuals with an age of onset of opioid use of 31 years or older (odds ratio 2.94, 95% confidence interval 1.20, 7.19, p = 0.02). A significant association was not found between the risk of having a comorbidity and an age of onset of opioid use between 18 and 25 years or 26 and 30 years, compared to an age of onset of opioid use of 31 years or older. CONCLUSION: Our study demonstrates that the younger one begins to use opioids, the greater their chance of having a physical or psychiatric co-morbidity. Understanding the risk posed by an earlier onset of opioid use for the later development of comorbid disorders informs clinical practice about important prognostic predictors and aids in the identification of high-risk patients.
PP - England
PY - 2017
SN - 1940-0640; 1940-0632
SP - 9
T1 - The association between age of onset of opioid use and comorbidity among opioid dependent patients receiving methadone maintenance therapy
T2 - Addiction science & clinical practice
TI - The association between age of onset of opioid use and comorbidity among opioid dependent patients receiving methadone maintenance therapy
U1 - Healthcare Disparities; Measures; Opioids & Substance Use
U2 - 28347350
U3 - 10.1186/s13722-017-0074-0
VL - 12
VO - 1940-0640; 1940-0632
Y1 - 2017
Y2 - Mar 28
ER -